6 news items
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
INCY
JAZZ
MIRA
23 Jul 24
have progressed after first-line treatment with other checkpoint inhibitors. “The trial aims to evaluate the safety and tolerability of THIO
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA
22 Jul 24
disorders. Ketamir-2 shows great promise in addressing these debilitating conditions with improved efficacy and safety, offering new hope and better quality
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
MIRA
15 Jul 24
outperformed THC in reducing anxiety driven behaviors and demonstrated a promising safety profile, potentially safer for human therapeutic use
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
MIRA
10 Jun 24
positive preclinical study results highlighting the potential efficacy and safety profile of Ketamir-2
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
MIRA
21 May 24
due to its potential for high oral bioavailability and lack of interaction with mu opioid receptors, which potentially enhances its safety profile
di7hpcx4xrpw8ba49nrouuklaqnwdqqhktaawghe8y7 8vzu
MIRA
20 May 24
toxicology studies with Frontage Laboratories. These studies are critical steps towards ensuring the safety and efficacy of Ketamir-2 in preparation
- Prev
- 1
- Next